By Distribution Channel

In-Network Specialty Pharmacy Market Analysis

Cross-industry research covering In-Network Specialty Pharmacy across 1 market reportspanning Pharmaceuticals & Medical Devices — Ophthalmic Surgery.

1 Reports

1 Industries

Reports Covering In-Network Specialty Pharmacy

Oculoplastic Surgery Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Medical Devices — Ophthalmic Surgery·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

The primary dispensing channel for TED biologics under commercial pharmacy benefit and Part D; specialty pharmacy networks (CVS Specialty, Accredo, Walgreens Specialty) impose prior authorization and step therapy requirements that can delay therapy initiation by 3–6 weeks for new TED biologic prescriptions (Claritas model).

18%

Market Share

9.4%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments